TCIIS
AZN icon

TIAA-CREF Individual & Institutional Services’s AstraZeneca AZN Stock Holding History

TIAA-CREF Individual & Institutional Services’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$664K Sell
3,505
-138
-4% -$26K ﹤0.01% 407
2026
Q1 		$718K Buy
+3,643
New +$702K ﹤0.01% 377

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

TIAA-CREF Individual & Institutional Services's AZN Position: Q2 2026 in Review

TIAA-CREF Individual & Institutional Services reduced its AstraZeneca (AZN) stake by 3.8% in Q2 2026, selling an estimated $26K and leaving 3,505 shares worth $664K. The position accounts for ﹤0.01% of the portfolio, ranked #407.

TIAA-CREF Individual & Institutional Services first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. The position peaked at $718K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • TIAA-CREF Individual & Institutional Services held 3,505 shares of AstraZeneca worth $664K as of Q2 2026.
  • TIAA-CREF Individual & Institutional Services sold 138 AstraZeneca shares in Q2 2026, an estimated $26K.
  • AstraZeneca made up ﹤0.01% of TIAA-CREF Individual & Institutional Services's portfolio in Q2 2026, its #407 holding.
  • TIAA-CREF Individual & Institutional Services first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
  • TIAA-CREF Individual & Institutional Services's AstraZeneca position peaked at $718K in Q1 2026.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on TIAA-CREF Individual & Institutional Services's 13F filing for Q2 2026, filed 10 Aug 2026.